(Q33723575)

28 July 2017

1 reference

title

The genetics of transitional cell carcinoma: progress and potential clinical application (English)

1 reference

transitional cell carcinoma

28 July 2017

1 reference

Knowles MA

1

1 reference

28 July 2017

1 September 1999

1 reference

28 July 2017

1 reference

28 July 2017

84

1 reference

28 July 2017

412-427

1 reference

28 July 2017

4

1 reference

Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors

28 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Oncogenes and bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Expression of G1-->S transition regulatory molecules in human urothelial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Detection of the c-myc gene product in urinary bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Expression of c-myc protein is related to cell proliferation and expression of growth factor receptors in transitional cell bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

A physical map of 30,000 human genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Cancer epigenetics comes of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Pten is essential for embryonic development and tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

21 January 2018

When checkpoints fail

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Identification of p53 gene mutations in bladder cancers and urine samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Altered Expression of Retinoblastoma Protein and Known Prognostic Variables in Locally Advanced Bladder Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

p53 immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Accumulation of nuclear p53 and tumor progression in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

A cell cycle regulator potentially involved in genesis of many tumor types

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Homozygous deletions but no sequence mutations in coding regions of p15 or p16 in human primary bladder tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Overcoming cellular senescence in human cancer pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Somatic mutation of PTEN in bladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Clonal origin of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

A novel candidate tumour suppressor locus at 9q32-33 in bladder cancer: localization of the candidate region within a single 840 kb YAC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

PTCH gene mutations in invasive transitional cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Identification and characterization of the human homologue of SH3BP2, an SH3 binding domain protein within a common region of deletion at 4p16.3 involved in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Deletion mapping of chromosome 11 in carcinoma of the bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Expression of cytokeratin 20 redefines urothelial papillomas of the bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Infrequent genetic alterations of the PTEN/MMAC1 gene in Japanese patients with primary cancers of the breast, lung, pancreas, kidney, and ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Laser capture microdissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Laser-capture microdissection: opening the microscopic frontier to molecular analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Mdm2 promotes the rapid degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

p14ARF links the tumour suppressors RB and p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Oncogene amplification in urothelial cancers with p53 gene mutation or MDM2 amplification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Deletion of the p16 and p15 Genes in Human Bladder Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

p19ARF links the tumour suppressor p53 to Ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

P16 gene in uncultured tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

Loss of genes on the short arm of chromosome 11 in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00217.X

10.1046/J.1464-410X.1999.00217.X

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10468754